Precision BioSciences Inc (DTIL) stock
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3068% above fair value
$7.40+0.49 (+7.09%)
Close on Nov 20, 2026Market cap $204.25MP/E –Yield –
Precision BioSciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Precision BioSciences's shares outstanding was 26M at Jun 30, 2026. For fiscal 2025 it was 13M, up 86.3% from the year before. The highest annual figure on record is 13M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13M | +86.3% |
| FY2024 | Dec 31, 2024 | 7M | +79.2% |
| FY2023 | Dec 31, 2023 | 4M | +31.1% |
| FY2022 | Dec 31, 2022 | 3M | +49.8% |
| FY2021 | Dec 31, 2021 | 2M | +12.8% |
| FY2020 | Dec 31, 2020 | 2M | +23.9% |
| FY2019 | Dec 31, 2019 | 1M | +166.2% |
| FY2018 | Dec 31, 2018 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 26M | +134.1% |
| Q1 FY2026 | Mar 31, 2026 | 25M | +165.1% |
| Q4 FY2025 | Dec 31, 2025 | 19M | +146.3% |
| Q3 FY2025 | Sep 30, 2025 | 12M | +62.2% |
| Q2 FY2025 | Jun 30, 2025 | 11M | +57.5% |
| Q1 FY2025 | Mar 31, 2025 | 9M | +83.5% |
| Q4 FY2024 | Dec 31, 2024 | 8M | +93.5% |
| Q3 FY2024 | Sep 30, 2024 | 7M | +89.8% |
| Q2 FY2024 | Jun 30, 2024 | 7M | +84.4% |
| Q1 FY2024 | Mar 31, 2024 | 5M | +36.5% |
| Q4 FY2023 | Dec 31, 2023 | 4M | +8.2% |
| Q3 FY2023 | Sep 30, 2023 | 4M | +3.9% |
| Q2 FY2023 | Jun 30, 2023 | 4M | +67.9% |
| Q1 FY2023 | Mar 31, 2023 | 4M | +82.4% |
| Q4 FY2022 | Dec 31, 2022 | 4M | +83.2% |
| Q3 FY2022 | Sep 30, 2022 | 4M | +85.8% |
| Q2 FY2022 | Jun 30, 2022 | 2M | +13.6% |
| Q1 FY2022 | Mar 31, 2022 | 2M | +7.8% |
| Q4 FY2021 | Dec 31, 2021 | 2M | +15.5% |
| Q3 FY2021 | Sep 30, 2021 | 2M | +14.0% |
| Q2 FY2021 | Jun 30, 2021 | 2M | +15.3% |
| Q1 FY2021 | Mar 31, 2021 | 2M | +10.4% |
| Q4 FY2020 | Dec 31, 2020 | 2M | +3.1% |
| Q3 FY2020 | Sep 30, 2020 | 2M | +3.4% |
| Q2 FY2020 | Jun 30, 2020 | 2M | +3.7% |
| Q1 FY2020 | Mar 31, 2020 | 2M | +221.4% |
| Q4 FY2019 | Dec 31, 2019 | 2M | +221.5% |
| Q3 FY2019 | Sep 30, 2019 | 2M | +220.1% |
| Q2 FY2019 | Jun 30, 2019 | 2M | +218.1% |
| Q1 FY2019 | Mar 31, 2019 | 1M | +1.7% |
| Q4 FY2018 | Dec 31, 2018 | 1M | – |
| Q3 FY2018 | Sep 30, 2018 | 1M | – |
| Q2 FY2018 | Jun 30, 2018 | 1M | – |
| Q1 FY2018 | Mar 31, 2018 | 1M | – |
See a number that looks wrong?